These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 35189702)
1. The Psychrotrophic Pseudomonas lundensis, a Non- Ravi K; Falkowski NR; Scales BS; Akulava VD; Valentovich LN; Huffnagle GB mBio; 2022 Feb; 13(1):e0386921. PubMed ID: 35189702 [TBL] [Abstract][Full Text] [Related]
2. Genome Sequences of Two Pseudomonas aeruginosa Isolates with Defects in Type III Secretion System Gene Expression from a Chronic Ankle Wound Infection. Karash S; Nordell R; Ozer EA; Yahr TL Microbiol Spectr; 2021 Sep; 9(1):e0034021. PubMed ID: 34259549 [TBL] [Abstract][Full Text] [Related]
3. Piericidin A1 Blocks Morgan JM; Duncan MC; Johnson KS; Diepold A; Lam H; Dupzyk AJ; Martin LR; Wong WR; Armitage JP; Linington RG; Auerbuch V mSphere; 2017; 2(1):. PubMed ID: 28217742 [TBL] [Abstract][Full Text] [Related]
4. The Impact of ExoS on Kroken AR; Chen CK; Evans DJ; Yahr TL; Fleiszig SMJ mBio; 2018 May; 9(3):. PubMed ID: 29717012 [No Abstract] [Full Text] [Related]
5. Antimicrobial Resistance and Type III Secretion System Virulotypes of Pseudomonas aeruginosa Isolates from Dogs and Cats in Primary Veterinary Hospitals in Japan: Identification of the International High-Risk Clone Sequence Type 235. Hayashi W; Izumi K; Yoshida S; Takizawa S; Sakaguchi K; Iyori K; Minoshima KI; Takano S; Kitagawa M; Nagano Y; Nagano N Microbiol Spectr; 2021 Oct; 9(2):e0040821. PubMed ID: 34585944 [TBL] [Abstract][Full Text] [Related]
6. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening. Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B; Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595 [TBL] [Abstract][Full Text] [Related]
7. Type III secretion system and virulence markers highlight similarities and differences between human- and plant-associated pseudomonads related to Pseudomonas fluorescens and P. putida. Mazurier S; Merieau A; Bergeau D; Decoin V; Sperandio D; Crépin A; Barbey C; Jeannot K; Vicré-Gibouin M; Plésiat P; Lemanceau P; Latour X Appl Environ Microbiol; 2015 Apr; 81(7):2579-90. PubMed ID: 25636837 [TBL] [Abstract][Full Text] [Related]
8. Novel type III effectors in Pseudomonas aeruginosa. Burstein D; Satanower S; Simovitch M; Belnik Y; Zehavi M; Yerushalmi G; Ben-Aroya S; Pupko T; Banin E mBio; 2015 Mar; 6(2):e00161. PubMed ID: 25784698 [TBL] [Abstract][Full Text] [Related]
9. Virulence and Metabolism Crosstalk: Impaired Activity of the Type Three Secretion System (T3SS) in a Gil-Gil T; Cuesta T; Hernando-Amado S; Reales-Calderón JA; Corona F; Linares JF; Martínez JL Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569678 [No Abstract] [Full Text] [Related]
10. Pseudomonas aeruginosa Magnesium Transporter MgtE Inhibits Type III Secretion System Gene Expression by Stimulating Chakravarty S; Melton CN; Bailin A; Yahr TL; Anderson GG J Bacteriol; 2017 Dec; 199(23):. PubMed ID: 28847924 [No Abstract] [Full Text] [Related]
11. Developing Cyclic Peptomers as Broad-Spectrum Type III Secretion System Inhibitors in Gram-Negative Bacteria. Lam HN; Lau T; Lentz A; Sherry J; Cabrera-Cortez A; Hug K; Lalljie A; Engel J; Lokey RS; Auerbuch V Antimicrob Agents Chemother; 2021 Jun; 65(7):e0169020. PubMed ID: 33875435 [TBL] [Abstract][Full Text] [Related]
12. Genetic and Environmental Investigation of a Novel Phenylamino Acetamide Inhibitor of the Pseudomonas aeruginosa Type III Secretion System. Fang L; Banerjee B; Yuan X; Zeng Q; Liang C; Chen X; Yang CH Appl Environ Microbiol; 2023 Jan; 89(1):e0175222. PubMed ID: 36519869 [TBL] [Abstract][Full Text] [Related]
13. Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media. Park MH; Kim SY; Roh EY; Lee HS Auris Nasus Larynx; 2017 Jun; 44(3):258-265. PubMed ID: 27461174 [TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa Antivirulence Strategies: Targeting the Type III Secretion System. Goldberg JB; Crisan CV; Luu JM Adv Exp Med Biol; 2022; 1386():257-280. PubMed ID: 36258075 [TBL] [Abstract][Full Text] [Related]
16. H-NS Family Members MvaT and MvaU Regulate the Pseudomonas aeruginosa Type III Secretion System. Williams McMackin EA; Marsden AE; Yahr TL J Bacteriol; 2019 Jul; 201(14):. PubMed ID: 30782629 [No Abstract] [Full Text] [Related]
17. The type III secretion system facilitates systemic infections of Wu T; Zhang Z; Li T; Dong X; Wu D; Zhu L; Xu K; Zhang Y Microbiol Spectr; 2024 Jan; 12(1):e0222423. PubMed ID: 38088541 [TBL] [Abstract][Full Text] [Related]
18. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa. Shi H; Chen Z; Kan J Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625 [TBL] [Abstract][Full Text] [Related]
19. PopB-PcrV Interactions Are Essential for Pore Formation in the Pseudomonas aeruginosa Type III Secretion System Translocon. Kundracik E; Trichka J; Díaz Aponte J; Roistacher A; Rietsch A mBio; 2022 Oct; 13(5):e0238122. PubMed ID: 36154276 [TBL] [Abstract][Full Text] [Related]
20. Fitting Pieces into the Puzzle of Williams McMackin EA; Djapgne L; Corley JM; Yahr TL J Bacteriol; 2019 Jul; 201(13):. PubMed ID: 31010903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]